Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-06

FDA Approved: NAFCILLIN — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a/ Avet Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for NAFCILLIN SODIUM (NAFCILLIN) from Heritage Pharmaceuticals Inc. (Avet Pharmaceuticals Inc.).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nafcillin (nafcillin)

Snippet

SUPPL AP for NAFCILLIN (NAFCILLIN SODIUM)